Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
24.59
-0.21 (-0.85%)
Apr 29, 2026, 9:45 AM EDT - Market open
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $3.09 billion as of April 29, 2026. Its market cap has increased by 256.80% in one year.
Market Cap
3.09B
Enterprise Value
2.32B
1-Year Change
256.80%
Ranking
Category
Stock Price
$24.59
Market Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $708.10M to $3.09B, an increase of 336.27%. That is a compound annual growth rate of 19.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 3.11B | 20.82% |
| Dec 31, 2025 | 2.57B | 88.83% |
| Dec 31, 2024 | 1.36B | -4.69% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | 1.69B | 263.86% |
| Dec 31, 2019 | 463.20M | -3.26% |
| Dec 31, 2018 | 478.80M | -32.38% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oruka Therapeutics | 3.47B |
| NewAmsterdam Pharma Company | 3.42B |
| Edgewise Therapeutics | 3.39B |
| Catalyst Pharmaceuticals | 3.34B |
| Structure Therapeutics | 3.22B |
| Alumis | 3.17B |
| Denali Therapeutics | 3.15B |
| Nektar Therapeutics | 3.09B |